BMTI

BIOMIMETIC THERAPEUTICS, INC.CIK 1138400 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for BMTI PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for BMTI

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Christensen Thorkil K.	Director	1	$0	$0	2013-03-01
Pagano Russell P.	VP, Reg. & Clinical Affairs	12	$0	$19.3K	2013-03-01
Novo A/S	10% Owner	1	$0	$0	2013-03-01
Friedlaender Gary E	Director	21	$60.8K	$0	2013-03-01
Lynch Samuel Eugene	President and CEO	26	$199.5K	$0	2013-03-01
Ehrlich Christopher B	Director	7	$0	$0	2013-03-01
MURPHY JAMES G	Director	10	$0	$0	2013-03-01
PAPASAN LARRY W	Director	14	$24.2K	$0	2013-03-01
FEDERICO CHARLES	Director	11	$0	$0	2013-03-01
BULLOCK LAWRENCE E	Chief Financial Officer	14	$44.0K	$0	2013-03-01
WATSON DOUGLAS G	Director	13	$0	$0	2013-03-01
Douglas Earl Martin	General Counsel	19	$0	$126.0K	2012-03-28

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Ehrlich Christopher B	Director	D To issuer deriv	2013-03-01	2013-03-05	5,831	—	$0	0	SEC↗
Ehrlich Christopher B	Director	D To issuer deriv	2013-03-01	2013-03-05	8,840	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	D To issuer deriv	2013-03-01	2013-03-05	75,000	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	D To issuer deriv	2013-03-01	2013-03-05	80,000	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	D To issuer deriv	2013-03-01	2013-03-05	80,000	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	D To issuer deriv	2013-03-01	2013-03-05	85,000	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	D To issuer deriv	2013-03-01	2013-03-05	205,703	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	D To issuer deriv	2013-03-01	2013-03-05	45,000	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	M Exercise deriv	2013-03-01	2013-03-05	170,000	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	M Exercise deriv	2013-03-01	2013-03-05	51,000	—	$0	0	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-05	112,500	—	$0	0	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-05	40,000	—	$0	0	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-05	37,500	—	$0	0	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-05	80,000	—	$0	0	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-05	27,000	—	$0	0	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-05	25,000	—	$0	0	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	D To issuer deriv	2013-03-01	2013-03-05	30,000	—	$0	0	SEC↗
PAPASAN LARRY W	Director	D To issuer deriv	2013-03-01	2013-03-05	8,840	—	$0	0	SEC↗
PAPASAN LARRY W	Director	M Exercise deriv	2013-03-01	2013-03-05	18,376	—	$0	0	SEC↗
PAPASAN LARRY W	Director	M Exercise deriv	2013-03-01	2013-03-05	20,000	—	$0	0	SEC↗
PAPASAN LARRY W	Director	D To issuer deriv	2013-03-01	2013-03-05	5,831	—	$0	0	SEC↗
PAPASAN LARRY W	Director	D To issuer deriv	2013-03-01	2013-03-05	10,653	—	$0	0	SEC↗
PAPASAN LARRY W	Director	D To issuer deriv	2013-03-01	2013-03-05	8,538	—	$0	0	SEC↗
WATSON DOUGLAS G	Director	D To issuer deriv	2013-03-01	2013-03-05	8,538	—	$0	0	SEC↗
WATSON DOUGLAS G	Director	M Exercise deriv	2013-03-01	2013-03-05	20,000	—	$0	0	SEC↗
WATSON DOUGLAS G	Director	D To issuer deriv	2013-03-01	2013-03-05	5,831	—	$0	0	SEC↗
WATSON DOUGLAS G	Director	M Exercise deriv	2013-03-01	2013-03-05	18,736	—	$0	0	SEC↗
WATSON DOUGLAS G	Director	D To issuer deriv	2013-03-01	2013-03-05	8,840	—	$0	0	SEC↗
WATSON DOUGLAS G	Director	D To issuer deriv	2013-03-01	2013-03-05	10,653	—	$0	0	SEC↗
MURPHY JAMES G	Director	D To issuer deriv	2013-03-01	2013-03-05	10,653	—	$0	0	SEC↗
MURPHY JAMES G	Director	D To issuer deriv	2013-03-01	2013-03-05	5,831	—	$0	0	SEC↗
MURPHY JAMES G	Director	M Exercise deriv	2013-03-01	2013-03-05	18,736	—	$0	0	SEC↗
MURPHY JAMES G	Director	M Exercise deriv	2013-03-01	2013-03-05	20,000	—	$0	0	SEC↗
MURPHY JAMES G	Director	D To issuer deriv	2013-03-01	2013-03-05	8,840	—	$0	0	SEC↗
MURPHY JAMES G	Director	D To issuer deriv	2013-03-01	2013-03-05	8,538	—	$0	0	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	D To issuer deriv	2013-03-01	2013-03-05	35,000	—	$0	0	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	D To issuer deriv	2013-03-01	2013-03-05	35,000	—	$0	0	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	D To issuer deriv	2013-03-01	2013-03-05	35,000	—	$0	0	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	D To issuer deriv	2013-03-01	2013-03-05	10,000	—	$0	0	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	M Exercise deriv	2013-03-01	2013-03-05	70,000	—	$0	0	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	D To issuer deriv	2013-03-01	2013-03-05	25,000	—	$0	0	SEC↗
FEDERICO CHARLES	Director	M Exercise deriv	2013-03-01	2013-03-05	20,000	—	$0	0	SEC↗
FEDERICO CHARLES	Director	D To issuer deriv	2013-03-01	2013-03-05	18,096	—	$0	0	SEC↗
FEDERICO CHARLES	Director	D To issuer deriv	2013-03-01	2013-03-05	8,538	—	$0	0	SEC↗
FEDERICO CHARLES	Director	M Exercise deriv	2013-03-01	2013-03-05	18,736	—	$0	0	SEC↗
FEDERICO CHARLES	Director	D To issuer deriv	2013-03-01	2013-03-05	8,840	—	$0	0	SEC↗
FEDERICO CHARLES	Director	D To issuer deriv	2013-03-01	2013-03-05	10,653	—	$0	0	SEC↗
Friedlaender Gary E	Director	D To issuer deriv	2013-03-01	2013-03-05	10,653	—	$0	0	SEC↗
Friedlaender Gary E	Director	M Exercise deriv	2013-03-01	2013-03-05	18,736	—	$0	0	SEC↗
Friedlaender Gary E	Director	M Exercise deriv	2013-03-01	2013-03-05	20,000	—	$0	0	SEC↗
Friedlaender Gary E	Director	D To issuer deriv	2013-03-01	2013-03-05	8,538	—	$0	0	SEC↗
Friedlaender Gary E	Director	D To issuer deriv	2013-03-01	2013-03-05	8,840	—	$0	0	SEC↗
Friedlaender Gary E	Director	D To issuer deriv	2013-03-01	2013-03-05	5,831	—	$0	0	SEC↗
WATSON DOUGLAS G	Director	D To issuer deriv	2013-03-01	2013-03-18	8,840	—	$0	0	SEC↗
WATSON DOUGLAS G	Director	D To issuer deriv	2013-03-01	2013-03-18	10,653	—	$0	0	SEC↗
WATSON DOUGLAS G	Director	D To issuer deriv	2013-03-01	2013-03-18	8,538	—	$0	0	SEC↗
Ehrlich Christopher B	Director	D To issuer	2013-03-01	2013-03-05	6,846	—	$0	0	SEC↗
Ehrlich Christopher B	Director	D To issuer	2013-03-01	2013-03-05	857,692	—	$0	0	SEC↗
Ehrlich Christopher B	Director	D To issuer	2013-03-01	2013-03-05	24,538	—	$0	0	SEC↗
Ehrlich Christopher B	Director	D To issuer	2013-03-01	2013-03-05	1,250	—	$0	0	SEC↗
Ehrlich Christopher B	Director	D To issuer	2013-03-01	2013-03-05	941,177	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	D To issuer	2013-03-01	2013-03-05	1,392,923	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	M Exercise	2013-03-01	2013-03-05	51,000	$3.47	$177.0K	1,300,546	SEC↗
Lynch Samuel Eugene	President and CEO	M Exercise	2013-03-01	2013-03-05	170,000	$2.08	$353.6K	1,470,546	SEC↗
Lynch Samuel Eugene	President and CEO	D To issuer	2013-03-01	2013-03-05	5,550	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	F Tax w/h	2013-03-01	2013-03-05	77,623	$9.07	$704.0K	1,392,923	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	D To issuer	2013-03-01	2013-03-05	89,151	—	$0	0	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	D To issuer	2013-03-01	2013-03-05	21,000	—	$0	0	SEC↗
PAPASAN LARRY W	Director	M Exercise	2013-03-01	2013-03-05	20,000	$2.63	$52.6K	69,517	SEC↗
PAPASAN LARRY W	Director	D To issuer	2013-03-01	2013-03-05	69,517	—	$0	0	SEC↗
PAPASAN LARRY W	Director	M Exercise	2013-03-01	2013-03-05	18,736	$5.80	$108.7K	49,517	SEC↗
WATSON DOUGLAS G	Director	M Exercise	2013-03-01	2013-03-05	20,000	$2.63	$52.6K	96,021	SEC↗
WATSON DOUGLAS G	Director	M Exercise	2013-03-01	2013-03-05	18,736	$5.80	$108.7K	76,021	SEC↗
WATSON DOUGLAS G	Director	D To issuer	2013-03-01	2013-03-05	96,021	—	$0	0	SEC↗
MURPHY JAMES G	Director	D To issuer	2013-03-01	2013-03-05	56,964	—	$0	0	SEC↗
MURPHY JAMES G	Director	M Exercise	2013-03-01	2013-03-05	20,000	$2.63	$52.6K	56,964	SEC↗
MURPHY JAMES G	Director	M Exercise	2013-03-01	2013-03-05	18,736	$5.80	$108.7K	36,964	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	F Tax w/h	2013-03-01	2013-03-05	32,305	$9.07	$293.0K	44,411	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	D To issuer	2013-03-01	2013-03-05	44,411	—	$0	0	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	M Exercise	2013-03-01	2013-03-05	70,000	$2.08	$145.6K	76,716	SEC↗
FEDERICO CHARLES	Director	F Tax w/h	2013-03-01	2013-03-05	11,977	$9.07	$108.6K	7,834	SEC↗
FEDERICO CHARLES	Director	M Exercise	2013-03-01	2013-03-05	18,736	$5.80	$108.7K	19,811	SEC↗
FEDERICO CHARLES	Director	M Exercise	2013-03-01	2013-03-05	20,000	$2.63	$52.6K	27,834	SEC↗
FEDERICO CHARLES	Director	D To issuer	2013-03-01	2013-03-05	27,834	—	$0	0	SEC↗
Friedlaender Gary E	Director	M Exercise	2013-03-01	2013-03-05	20,000	$2.63	$52.6K	70,754	SEC↗
Friedlaender Gary E	Director	F Tax w/h	2013-03-01	2013-03-05	5,797	$9.07	$52.6K	64,957	SEC↗
Friedlaender Gary E	Director	M Exercise	2013-03-01	2013-03-05	18,736	$5.80	$108.7K	62,731	SEC↗
Friedlaender Gary E	Director	F Tax w/h	2013-03-01	2013-03-05	11,977	$9.07	$108.6K	50,754	SEC↗
Friedlaender Gary E	Director	D To issuer	2013-03-01	2013-03-05	4,258	—	$0	0	SEC↗
Friedlaender Gary E	Director	D To issuer	2013-03-01	2013-03-05	3,377	—	$0	0	SEC↗
Friedlaender Gary E	Director	D To issuer	2013-03-01	2013-03-05	4,258	—	$0	0	SEC↗
Friedlaender Gary E	Director	D To issuer	2013-03-01	2013-03-05	11,762	—	$0	0	SEC↗
Friedlaender Gary E	Director	D To issuer	2013-03-01	2013-03-05	64,957	—	$0	0	SEC↗
Friedlaender Gary E	Director	D To issuer	2013-03-01	2013-03-05	14,894	—	$0	0	SEC↗
Christensen Thorkil K.	Director	D To issuer	2013-03-01	2013-03-06	2,507	—	$0	0	SEC↗
Novo A/S	10% Owner	D To issuer	2013-03-01	2013-03-06	4,720,065	—	$0	0	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	S Sale	2013-01-22	2013-01-24	1,381	$8.10	$11.2K	6,716	SEC↗
FEDERICO CHARLES	Director	A Award deriv	2012-06-11	2012-06-12	20,000	—	$0	20,000	SEC↗
Friedlaender Gary E	Director	A Award deriv	2012-06-11	2012-06-12	20,000	—	$0	20,000	SEC↗
MURPHY JAMES G	Director	A Award deriv	2012-06-11	2012-06-12	20,000	—	$0	20,000	SEC↗
PAPASAN LARRY W	Director	A Award deriv	2012-06-11	2012-06-12	20,000	—	$0	20,000	SEC↗
WATSON DOUGLAS G	Director	A Award deriv	2012-06-11	2012-06-12	20,000	—	$0	20,000	SEC↗
Friedlaender Gary E	Director	P Buy	2012-04-02	2012-04-04	10,000	$2.79	$27.9K	43,995	SEC↗
Lynch Samuel Eugene	President and CEO	P Buy	2012-03-30	2012-03-30	19,362	$2.46	$47.6K	1,219,391	SEC↗
Lynch Samuel Eugene	President and CEO	P Buy	2012-03-30	2012-03-30	20,000	$2.40	$48.0K	1,239,391	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	S Sale	2012-03-29	2012-04-16	3,438	$2.36	$8.1K	5,996	SEC↗
Lynch Samuel Eugene	President and CEO	P Buy	2012-03-29	2012-03-30	30,638	$2.38	$72.9K	1,200,029	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	5,000	$2.35	$11.8K	53,517	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	1,100	$2.32	$2.6K	52,417	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	200	$2.33	$466	52,217	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	3,300	$2.34	$7.7K	48,917	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	1,400	$2.33	$3.3K	47,517	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	6,000	$2.35	$14.1K	41,517	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	3,000	$2.34	$7.0K	38,517	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	5,000	$2.36	$11.8K	33,517	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	1,300	$2.35	$3.1K	32,217	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	400	$2.35	$940	31,817	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	300	$2.35	$705	31,517	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	2,000	$2.36	$4.7K	29,517	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	5,000	$2.37	$11.8K	24,517	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	8,000	$2.35	$18.8K	11,056	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	461	$2.37	$1.1K	19,056	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-28	2012-03-28	5,000	$2.38	$11.9K	19,517	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-27	2012-03-28	5,000	$2.34	$11.7K	58,517	SEC↗
PAPASAN LARRY W	Director	P Buy	2012-03-27	2012-03-29	3,000	$2.32	$7.0K	25,381	SEC↗
PAPASAN LARRY W	Director	P Buy	2012-03-27	2012-03-29	2,000	$2.32	$4.6K	22,381	SEC↗
PAPASAN LARRY W	Director	P Buy	2012-03-27	2012-03-29	3,000	$2.32	$7.0K	28,381	SEC↗
PAPASAN LARRY W	Director	P Buy	2012-03-27	2012-03-29	2,400	$2.34	$5.6K	30,781	SEC↗
Douglas Earl Martin	General Counsel	S Sale	2012-03-26	2012-03-28	1,100	$2.35	$2.6K	63,517	SEC↗
Lynch Samuel Eugene	President and CEO	P Buy	2012-03-23	2012-03-28	2,700	$2.35	$6.3K	1,169,391	SEC↗
Lynch Samuel Eugene	President and CEO	P Buy	2012-03-23	2012-03-28	10,000	$2.35	$23.5K	1,166,691	SEC↗
Lynch Samuel Eugene	President and CEO	P Buy	2012-03-23	2012-03-28	450	$2.35	$1.1K	5,550	SEC↗
Lynch Samuel Eugene	President and CEO	G Gift	2012-03-20	2012-03-21	100,000	—	$0	1,114,422	SEC↗
Lynch Samuel Eugene	President and CEO	J Other	2012-03-20	2012-03-21	42,269	—	$0	0	SEC↗
Lynch Samuel Eugene	President and CEO	G Gift	2012-03-20	2012-03-21	100,000	—	$0	42,269	SEC↗
Lynch Samuel Eugene	President and CEO	J Other	2012-03-20	2012-03-21	42,269	—	$0	1,156,691	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	P Buy	2012-03-20	2012-03-21	17,670	$2.20	$38.9K	78,723	SEC↗
Friedlaender Gary E	Director	P Buy	2012-03-19	2012-03-21	5,000	$2.18	$10.9K	14,894	SEC↗
Friedlaender Gary E	Director	P Buy	2012-03-19	2012-03-21	5,000	$2.20	$11.0K	33,995	SEC↗
Friedlaender Gary E	Director	P Buy	2012-03-19	2012-03-21	5,000	$2.19	$10.9K	11,762	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	P Buy	2012-03-19	2012-03-21	2,330	$2.20	$5.1K	61,053	SEC↗
Pagano Russell P.	VP, Reg. & Clinical Affairs	A Award deriv	2012-02-29	2012-03-02	70,000	—	$0	70,000	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	A Award deriv	2012-02-29	2012-03-02	80,000	—	$0	80,000	SEC↗
Douglas Earl Martin	General Counsel	A Award deriv	2012-02-29	2012-03-02	80,000	—	$0	80,000	SEC↗
Lynch Samuel Eugene	President and CEO	A Award deriv	2012-02-29	2012-03-02	170,000	—	$0	170,000	SEC↗
Lynch Samuel Eugene	President and CEO	G Gift	2011-11-16	2012-02-13	112,072	—	$0	1,014,422	SEC↗
Lynch Samuel Eugene	President and CEO	G Gift	2011-11-16	2012-02-13	112,072	—	$0	142,269	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	G Gift	2011-10-11	2012-02-13	16,000	—	$0	28,000	SEC↗
BULLOCK LAWRENCE E	Chief Financial Officer	G Gift	2011-10-11	2012-02-13	16,000	—	$0	58,723	SEC↗